Deal Announcements

Critical Biologics Finishes Series A

Monday, August 25, 2008 5:43:00 AM PDT | VentureDeal Staff

Cambridge, Massachusetts --  Biotech company Critical Biologics Corp. has received an additional $1.5 million in its first round of institutional funding, according to a report in VentureWire.

The company is focused on developing technology for a "theranostic approach to treat critical care patients with low plasma gelsolin levels at high risk of life-threatening complications."

The additional funding was provided by an undisclosed party. The company said that the additional funding will enable it to advance its lead human plasma gelsolin compound.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1